PlainPatent
USPTO 2015–2025 USPTO PatentsView US Corporation

IFGCure Holdings, LLC

USPTO PatentsView assignee record — 18 granted patents across 8 technology areas, active 2019–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).

Explore the portfolio See the ranking
18
Total patents granted
8
CPC technology areas
6.0
Avg claims per patent
+0%
5-year filing velocity

Portfolio overview

IFGCure Holdings, LLC has been granted 18 US utility patents between 2019 and 2024, placing IFGCure Holdings, LLC at rank #16,094 across all assignees tracked by PlainPatent. This portfolio spans 8 distinct Cooperative Patent Classification (CPC) subclasses, averaging 6.0 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a US Corporation, IFGCure Holdings, LLC is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 25.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 9 grants, compared with 9 in the 2015–2019 window — a +0% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. IFGCure Holdings, LLC's 6.0 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 8 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark IFGCure Holdings, LLC against peers pursuing similar technology classes.

How does IFGCure compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows IFGCure holds 18 patents — placing it at rank #16,094 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2019–2024

0246810 20192020202120222024 1
USPTO utility patent grants by year · 2019–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table
IFGCure Holdings, LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2019 9 50.0%
2020 3 16.7%
2021 3 16.7%
2022 2 11.1%
2024 1 5.6%

Which technologies does IFGCure Holdings, LLC patent most?

Top 8 of 8 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Simple
Velocity Growing

Where it ranks

Overall rank by patents

#16,094

Across all tracked assignees

Innovation Score

25.1 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does IFGCure Holdings, LLC hold?
IFGCure Holdings, LLC holds 18 US granted patents filed between 2019 and 2024, spanning 8 technology areas.
What is IFGCure Holdings, LLC's Innovation Score?
IFGCure Holdings, LLC has an Innovation Score of 25.1 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does IFGCure Holdings, LLC focus on?
IFGCure Holdings, LLC's top technology area is A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS) with 7 patents. The company has filed patents in 8 CPC subclasses total.
Is IFGCure Holdings, LLC's patent filing rate increasing or decreasing?
IFGCure Holdings, LLC's recent filing velocity is +0% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for IFGCure Holdings, LLC's patents?
IFGCure Holdings, LLC's patents average 6.0 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the IFGCure Holdings, LLC patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

How Innovation Score Works

Understand the four dimensions behind the composite score
How to Read Patent Data

Plain-English guide to CPC codes, claims, and metrics
Patent Moat Analysis

How companies use patents as competitive barriers

Explore the patent dataset

A61F technology

IFGCure Holdings, LLC's primary CPC class — all holders and yearly trends
Top 50 patent holders

See where IFGCure Holdings, LLC ranks among the largest US patent assignees
All technology classes

Browse every CPC technology area by patent activity
How the score works

The four dimensions behind the Innovation Score

Related

All companies → | All technologies → | Rankings →
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology — how this data is sourced, computed, and verified.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope